# A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)

> **NCT07435194** · PHASE1 · RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 28 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MK-2828
- **DRUG:** Itraconazole
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT07435194
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-06
- **Primary completion:** 2026-08-12
- **Final completion:** 2026-08-12
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07435194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07435194, "A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07435194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*